Gene-environment interactions for complex traits: Definitions, methodological requirements and challenges
Astrid Dempfle,André Scherag,André Scherag,Rebecca Hein,Lars Beckmann,Jenny Chang-Claude,Helmut Schäfer +6 more
TLDR
This review discusses methodological issues involved in investigating gene–environment (G × E) interactions in genetic–epidemiological studies of complex diseases and their potential relevance for clinical application and attempts to clarify conceptual differences of the term ‘interaction’ in the statistical and biological sciences.Abstract:
Genetic and environmental risk factors and their interactions contribute to the development of complex diseases In this review, we discuss methodological issues involved in investigating gene-environment (G x E) interactions in genetic-epidemiological studies of complex diseases and their potential relevance for clinical application Although there are some important examples of interactions and applications, the widespread use of the knowledge about G x E interaction for targeted intervention or personalized treatment (pharmacogenetics) is still beyond current means This is due to the fact that convincing evidence and high predictive or discriminative power are necessary conditions for usefulness in clinical practice We attempt to clarify conceptual differences of the term 'interaction' in the statistical and biological sciences, since precise definitions are important for the interpretation of results We argue that the investigation of G x E interactions is more rewarding for the detailed characterization of identified disease genes (ie at advanced stages of genetic research) and the stratified analysis of environmental effects by genotype or vice versa Advantages and disadvantages of different epidemiological study designs are given and sample size requirements are exemplified These issues as well as a critical appraisal of common methodological concerns are finally discussedread more
Citations
More filters
Journal ArticleDOI
Prediction and Interaction in Complex Disease Genetics: Experience in Type 1 Diabetes
TL;DR: These two topics concern the use and interpretation of statistical models for risk of diseases with several, perhaps many, etiological risk factors, and were both the subject of lively debate some 30 to 40 years ago when such models first came into widespread use in epidemiology.
Journal ArticleDOI
Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences.
J. Carlos Pastor,Jimena Rojas,Jimena Rojas,Salvador Pastor-Idoate,Salvador Pastor-Idoate,Salvatore Di Lauro,Lucia Gonzalez-Buendia,Santiago Delgado-Tirado +7 more
TL;DR: Inflammation is one of the major components of PVR, and new genetic biomarkers that have the potential to predict its development are described, including one directed towards neuroprotection, which can also be useful for preventing visual loss after any RD.
Journal ArticleDOI
The evidence for a role of B cells in multiple sclerosis
TL;DR: There is no longer doubt that B cells are relevant to the etiology and pathogenesis of MS and elucidating the role of B cells in MS will be a fruitful strategy for disease prevention and treatment.
Journal ArticleDOI
Genetic screening for the risk of type 2 diabetes: worthless or valuable?
TL;DR: It is demonstrated that first-degree family history is associated with twofold increased risk of future type 2 diabetes, and advances in genotyping technology during the last 5 years have facilitated rapid progress in large-scale genetic studies.
Journal ArticleDOI
The gene, environment association studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions
Marilyn C. Cornelis,Arpana Agrawal,John W. Cole,Nadia N. Hansel,Kathleen C. Barnes,Terri H. Beaty,Siiri N. Bennett,Laura J. Bierut,Eric Boerwinkle,Kimberly F. Doheny,Bjarke Feenstra,Eleanor Feingold,Myriam Fornage,Christopher A. Haiman,Emily L. Harris,M. Geoffrey Hayes,John A. Heit,Frank B. Hu,Jae H. Kang,Cathy C. Laurie,Hua Ling,Teri A. Manolio,Mary L. Marazita,Rasika A. Mathias,Daniel B. Mirel,Justin Paschall,Louis R. Pasquale,Elizabeth W. Pugh,John P. Rice,Jenna Udren,Rob M. van Dam,Xiaojing Wang,Janey L. Wiggs,Kayleen Williams,Kai Yu +34 more
TL;DR: The Gene, Environment Association Studies (GENEVA) consortium was initiated to identify genetic variants related to complex diseases; identify variations in gene‐trait associations related to environmental exposures; and ensure rapid sharing of data through the database of Genotypes and Phenotypes.
References
More filters
Journal ArticleDOI
Trick or treat: The effect of placebo on the power of pharmacogenetic association studies
Clara Singer,Iris Grossman,Iris Grossman,Nili Avidan,Jacques S. Beckmann,Jacques S. Beckmann,Itsik Pe'er +6 more
TL;DR: It is shown that the placebo 'response' strongly affects the statistical power of association studies -- even a highly penetrant drug-response allele requires at least a 500-patient trial in order to reach 80 per cent power, several-fold more than the value estimated by standard tools that are not calibrated to pharmacogenetics.
Book ChapterDOI
24 The role of interacting determinants in the localization of genes
W. James Gauderman,Duncan Thomas +1 more
TL;DR: It is found that a test of heterogeneity in IBD sharing probabilities across strata defined by sharing of environmental factors can offer greater power for detecting linkage than the simple mean test, provided the interaction effect is sufficiently strong.
Journal ArticleDOI
Testing linkage and gene x environment interaction: comparison of different affected sib-pair methods.
TL;DR: Results showed that when exposure cancels the effect of the gene, or changes the direction of this effect (i.e., the protective allele becomes the risk allele), the PST, sMLS, and MIT may provide, under some models, greater power to detect linkage than the MLS.
Journal ArticleDOI
Sample Size Calculations for Main Effects and Interactions in Case–control Studies using Stata's nchi2 and npnchi2 Functions:
TL;DR: In this article, the non-central � 2 distribution is used to calculate power for t ests detecting departure from a null hypothesis and required sample size is proportional to the noncentrality parameter for the distribution.
Journal ArticleDOI
Using Multiple Drug Exposure Levels to Optimize Power in Pharmacogenetic Trials
TL;DR: The conclusion is that trial designs that use more than one drug exposure or dose will have an increased likelihood of discovering statistically significant pharmacogenetic associations.
Related Papers (5)
Finding the missing heritability of complex diseases
Teri A. Manolio,Francis S. Collins,Nancy J. Cox,David Goldstein,Lucia A. Hindorff,David J. Hunter,Mark I. McCarthy,Erin M. Ramos,Lon R. Cardon,Aravinda Chakravarti,Judy H. Cho,Alan E. Guttmacher,Augustine Kong,Leonid Kruglyak,Leonid Kruglyak,Elaine R. Mardis,Charles N. Rotimi,Montgomery Slatkin,David Valle,Alice S. Whittemore,Michael Boehnke,Andrew G. Clark,Evan E. Eichler,Greg Gibson,Jonathan L. Haines,Trudy F. C. Mackay,Steven A. McCarroll,Peter M. Visscher +27 more
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity
Timothy M. Frayling,Nicholas J. Timpson,Michael N. Weedon,Eleftheria Zeggini,Eleftheria Zeggini,Eleftheria Zeggini,Rachel M. Freathy,Cecilia M. Lindgren,John R. B. Perry,Katherine S. Elliott,Katherine S. Elliott,Hana Lango,Nigel W. Rayner,Nigel W. Rayner,Nigel W. Rayner,Beverley M. Shields,Lorna W. Harries,Jeffrey C. Barrett,Jeffrey C. Barrett,Sian Ellard,Christopher J. Groves,Christopher J. Groves,Bridget A. Knight,Ann-Marie Patch,Andy R Ness,Shah Ebrahim,Debbie A Lawlor,Susan M. Ring,Yoav Ben-Shlomo,Marjo-Riitta Järvelin,Marjo-Riitta Järvelin,Ulla Sovio,Ulla Sovio,Amanda J. Bennett,Amanda J. Bennett,David Melzer,Luigi Ferrucci,Ruth J. F. Loos,Inês Barroso,Nicholas J. Wareham,Fredrik Karpe,Fredrik Karpe,Katharine R. Owen,Katharine R. Owen,Lon R. Cardon,Mark Walker,Graham A. Hitman,Graham A. Hitman,Colin N. A. Palmer,Colin N. A. Palmer,Alex S. F. Doney,Alex S. F. Doney,Andrew D. Morris,George Davey Smith,Andrew T. Hattersley,Mark I. McCarthy +55 more